[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-334271-105":59,"doc-detail-334271-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","pushing-the-boundaries-of-radiotherapy-immunotherapy-combinations-highlights-from-the-7th-immunorad-conference","Pushing the boundaries of radiotherapy-immunotherapy combinations: highlights from the 7th immunorad conference","","Conference highlights focused on advancing radiotherapy–immunotherapy combinations, presenting key scientific contributions from the 7th immunorad meeting. The document lists a large multi-institution author group and detailed affiliations spanning radiation oncology, medical oncology, nuclear medicine, immunology, translational research, and precision medicine. It indicates a collaborative, research-driven effort aimed at therapeutic innovations and molecularly guided strategies in cancer treatment, reflecting broad international participation across Europe and North America.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/pushing-the-boundaries-of-radiotherapy-immunotherapy-combinations-highlights-from-the-7th-immunorad-conference/334271/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/pushing-the-boundaries-of-radiotherapy-immunotherapy-combinations-highlights-from-the-7th-immunorad-conference/334271.png","ImageObject",300,407,{"name":92,"@type":93},"Genevieve","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-06","2026-09-21",true,{"@type":102,"interactionType":103,"userInteractionCount":44},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What is the main focus of the 7th immunorad conference highlights?","Question",{"text":112,"@type":113},"The document centers on pushing the boundaries of radiotherapy-immunotherapy combinations and summarizes key conference contributions.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How many organizations and specialties are reflected in the author affiliations?",{"text":117,"@type":113},"It includes many affiliations covering radiation oncology, medical oncology, immunology, nuclear medicine, and translational/precision medicine research.",{"name":119,"@type":110,"acceptedAnswer":120},"Who are the primary contributor group mentioned in the document?",{"text":121,"@type":113},"The author list consists of a large, multi-institution team associated with cancer research and clinical oncology units.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},334271,1790701949,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":44,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":66,"faqs":141,"seo_title":142,"seo_description":67,"update_tm":143,"read_time":144,"preview_page_count":4},1374391974585,"https://ap-avatar.wpscdn.com/davatar_276721f389ce27ea32af1340a28f341c","Pushing the boundaries of radiotherapy-immunotherapy combinations: highlights from the 7th immunorad conference  \nPierre-Antoine Laurenta,b, Fabrice Andréc,d,e, Alexandre Bobardf, Desiree Deandreisg, Sandra Demariah,i,j,  \nStephane Depilk,l, Stefan B. Eichmüllerm, Cristian Fernandez-Palomon, Floris Foijero, Lorenzo Galluzzih,j,p, Jérôme Galonq,r, Matthias Guckenbergers, Kevin J. Harringtont, Fernanda G. Herrerau,v,w, Peter E. Huberx,y, Antoine Italianoz,aa,bb,  \nSana D. Karamcc,dd, Guido Kroemeree,ff,gg,hh, Philippe Lambin ii,jj, Carola Leuschnerkk, Alberto Mantovanill,mm, Etienne Meylannn,oo,pp, Michele Mondini b, Mikael J. Pittetw,qq,rr,ss,tt, Jean-Pierre Pougetuu, Jordi Remonc, Claus S. Sørensenvv, Christos Sotiriouww, Claire Vanpouille-Boxh,j, Ralph R. Weichselbaumxx, James W. Welshkk, Laurence Zitvogelyy,zz,aaa,bbb, Silvia C. Formentih,j, and Eric Deutsch a,b,bbb,ccc  \naDepartment of Radiation Oncology, Gustave Roussy, Villejuif, France; bINSERM, U1030 “Molecular Radiotherapy and Therapeutic Innovations”, Gustave Roussy, Villejuif, France; cDepartment of Medical Oncology, Gustave Roussy, Villejuif, France; dINSERM U981 “Molecular predictors and new targets in oncology”, Gustave Roussy, Villejuif, France; eIHU PRISM Precision Medicine Cancer Center, Gustave Roussy, Villejuif, France; fSIRIC EpiCURE, Gustave Roussy, Villejuif, France; gDivision of Nuclear Medicine, Gustave Roussy, Villejuif, France; hDepartment of Radiation Oncology, Weill Cornell Medicine, New-York, NY, USA; iDepartment of Pathology and Laboratory Medicine, Weill Cornell Medicine, New-York, NY, USA; jSandra and Edward Meyer Cancer Center, New York, NY, USA; kCancer Research Center of Lyon, Centre Léon Bérard, Université Claude Bernard, Lyon, France; lErVimmune, Lyon, France; m Research Group GMP & T-cell therapy, Deutsches Krebsforschungszentrum (DKFZ), Heidelberg, Germany; n Institute of Anatomy, University of Bern, Bern, Switzerland; o European Research Institute for the Biology of Ageing, University of Groningen, University Medical Center Groningen, Groningen, the Netherlands; pCaryl and Israel Englander Institute for Precision Medicine, New York, NY, USA; qINSERM, Laboratory of Integrative Cancer Immunology; Sorbonne Université; Sorbonne Paris Cité, Université de Paris, Paris, France; rCentre de Recherche des Cordeliers, Paris, France; sDepartment of Radiation Oncology, University Hospital Zurich, Zurich, Switzerland; tThe Institute of Cancer Research and The Royal Marsden NHS Foundation Trust, National Institute of Health Research Biomedical Research Centre, London, UK; u Radiation Oncology Service, Department of Oncology, Lausanne University Hospital, Lausanne, Switzerland; vImmuno-oncology Service, Department of Oncology, Lausanne University Hospital, Lausanne, Switzerland; w Ludwig Institute for Cancer Research, University of Lausanne, Lausanne, Switzerland; xDepartment of Radio-oncology and Radiotherapy, University Hospital Heidelberg; Heidelberg Institute for Radiation Oncology (HIRO), Heidelberg, Germany; yDepartment of Molecular and Radiation Oncology, German Cancer Research Center (DKFZ), Heidelberg, Germany; z Department of therapeutic innovations (DITEP), Gustave Roussy, Villejuif, France; aa Department of Medicine, Institut Bergonié, Bordeaux, France; bbFaculty of Medicine, University of Bordeaux, Bordeaux, France; cc Department of Radiation Oncology, University of Colorado Anschutz Medical Campus, Aurora, CO, USA; ddDepartment of Immunology and Microbiology, University of Colorado Anschutz Medical Campus, Aurora, CO, USA; eeCentre de Recherche des Cordeliers, Université de Paris Cité, Sorbonne Université, Paris, France; ffMetabolomics and Cell Biology Platforms, Gustave Roussy, Villejuif, France; ggDepartment of Biology, Hôpital Européen Georges Pompidou AP-HP, Paris, France; hhInstitut du Cancer Paris CARPEM, Paris, France; iiDepartment of Precision Medicine, GROW-Research Institute for Oncology and Reproduction, Maastricht University, Ma","cbCaifRtSPEEP1uL","https://ap.wps.com/l/cbCaifRtSPEEP1uL","pdf",4042411,13,"English","[{\"question\":\"What is the main focus of the 7th immunorad conference highlights?\",\"answer\":\"The document centers on pushing the boundaries of radiotherapy-immunotherapy combinations and summarizes key conference contributions.\"},{\"question\":\"How many organizations and specialties are reflected in the author affiliations?\",\"answer\":\"It includes many affiliations covering radiation oncology, medical oncology, immunology, nuclear medicine, and translational/precision medicine research.\"},{\"question\":\"Who are the primary contributor group mentioned in the document?\",\"answer\":\"The author list consists of a large, multi-institution team associated with cancer research and clinical oncology units.\"}]","Pushing the boundaries of radiotherapy-immunotherapy combinations: highlights from the 7th immunorad conference | PDF",1790006089,33]